
|
Report Date : |
26.04.2007 |
IDENTIFICATION
DETAILS
|
Name : |
LEADS PHARMA (PRIVATE) LIMITED |
|
|
|
|
Formerly Known As : |
VETY-CARE PHARMACEUTICALS (PVT.) LIMITED |
|
|
|
|
Registered Office : |
Plot # 81-A, Street # 6, I-10/3 Islamabad |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1995 |
|
|
|
|
Com. Reg. No.: |
00001737
|
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of Veterinary Medicines |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
Business Name
LEADS PHARMA (PRIVATE) LIMITED
FORMERLY
VETY-CARE PHARMACEUTICALS (PVT.) LIMITED
Full Address
|
Registered Address |
|
Plot # 81-A, Street # 6, I-10/3 Islamabad, Pakistan |
|
Tel |
92 (51) 4441081,
4441082, 4441083, 111-103-103 |
|
Fax |
92 (51) 4441080 |
|
|
Short Description Of
Business
|
Nature of Business |
Manufacture & Marketing of Veterinary Medicines |
|
Year Established |
1995 |
|
Registration # |
00001737
|
Branches
|
Address |
Flat #
14-B, 1st Floor, Agro Base Flat, Shadman Market |
|
Tel # |
92
(42) 7551398, 7569004 |
|
Fax # |
92 (42) 7590319 |
|
Address |
Room #
301, Anum Blessing Near Duty Free Shop, Block # 7 & 8, K.CH.S. Karachi,
Pakistan |
|
Tel # |
92
(21) 4544618, 4544619 |
|
Fax # |
92 (21) 4544619 |
Auditors
Amir Alam Khan &
Co.
(Chartered Accountants)
55/1, Bank Road, Rawalpindi, Pakistan
Legal Advisor
Sofia Hummayun, Rawalpindi, Islamabad, Pakistan.
Legal Status
Subject Company was established as a Private Limited Company in 1995
|
Authorised Capital |
Rs. 50,000,000
divided into 500,000 shares of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs. 20,000,000
divided into 200,000 shares of Rs. 100/- each |
Details of Directors
|
Names |
Nationality |
Address |
Designation |
|
Dr. Mohammad Amjad Mrs. Tammina Amjad Dr. Mohammad Aslam Azam Mr. Syed Abid Nisar |
Pakistani Pakistani Pakistani Pakistani |
H # 96, Main Double Road, F 10/1, Islamabad, H # 96, Main Double Road, F 10/1, Islamabad, H # 70, St. # 32, F-6/1, Islamabad Plot # 81-A, Street # 6, I-10/3 Islamabad |
Chief Executive Director Director Director |
Shareholders
|
Names |
Address |
Shareholding (%) |
|
Dr. Mohammad Aslam Azam Mrs. Tammina Amjad Dr. Mohammad Amjad Mrs. Tehmina Amjad Mr. Jahanzeb Amjad Miss Muriam Amjad Maj. (Rtd) Sardar Aman-ullah Mrs. Hasina Aman Miss Aysha Aman Mr. Shoukat Ullah |
H # 70, St. # 32, F-6/1, Islamabad. H # 96, Main Double Road, F 10/1, Islamabad. H # 96, Main Double Road, F 10/1, Islamabad. H # 96, Main Double Road, F 10/1, Islamabad. H # 96, Main Double Road, F 10/1, Islamabad. H # 96, Main Double Road, F 10/1, Islamabad. H # 9-B, St # 42, F-7/1, Islamabad. H # 9-B, St # 42, F-7/1, Islamabad. H # 9-B, St # 42, F-7/1, Islamabad. H # 673, B-11, Mohallah Faizabad, Ward 16, the District. Lieya |
9.8 4.8 45.8 10 5 5 5.93 2 1.9 9.77 |
Associates
Subsidiary
None
Associated Companies
Vety-Care (Pvt.) Ltd.
Quality Poultry Breeders.
Bio-Veterinary Pharma.
Quality Feeds.
Poultry Diagnostic Lab.
Product/Services
Principally engaged in the manufacture of poultry and livestock quality drugs within
the country.
Number of Employees
130
Annual Sales Volume
(In Pak Rupees)
Rs. 150,000,000/- (Estimated)
Agencies (Foreign)
Bremer Pharma, Germany.
Intervet International, Holland.
Arbor Acres, USA.
Roxell, Belgium.
Pharmacia & Upjohn, Belgium.
Lohman, Germany.
Distributors
(Nationwide)
(1) Excel Care, Gujranwala, Lahore, Pakistan.
(2) Bilal Traders, Faisalabad, Pakistan
(3) Animal & Poultry Helth Services, Peshawar,
Pakistan.
(4) Khan Traders, Sarghoda, Pakistan.
(5) Saddiqui Poultry Services, Multan, Pakistan.
(6) Mr. Usman Ghani, Dera Ismail Khan, Pakistan.
(7) Khushall Interprises, Quetta, Pakistan.
Bankers
ABN AMRO Bank Limited, Pakistan.
Muslim Commercial Bank Limited, Pakistan.
Faysal Bank Limited, Pakistan.
Habib Bank Limited, Pakistan.(Mortgage obtained PKR 18,134,830/-)
Financial Position
Satisfactory
Foreign Exchange
Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 60.70 |
|
UK Pound |
1 |
Rs. 121.35 |
|
Euro |
1 |
Rs. 82.55 |
Comments
The conduct of the company is correct and the mode of payment prompt no complaints have been heard regarding payments to local suppliers. The Company can be considered for normal business dealings at usual trade terms and conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)